Philippines FDA registration CMDR-2021-00323

ACURATE NEO2™ TRANSFEMORAL DELIVERY SYSTEM AORTIC TRANSCATHETER HEART VALVE BIO-PROSTHETIC, SCENT-LIKE FRAMEWORK

Philippines flagPhilippines·Boston Scientific Corporation - MA, USA mfd. By: Symetis SA - Ecublens, Switzerland·Switzerland·Issued December 07, 2021 – December 07, 2026
Device information
Product Name
ACURATE NEO2™ TRANSFEMORAL DELIVERY SYSTEM AORTIC TRANSCATHETER HEART VALVE BIO-PROSTHETIC, SCENT-LIKE FRAMEWORK
Registration Number
CMDR-2021-00323
Manufacturer details
Country of Origin
Switzerland
Importer & distribution
Registration dates
Issuance Date
December 07, 2021
Expiry Date
December 07, 2026
About this record

Access comprehensive regulatory information for ACURATE NEO2™ TRANSFEMORAL DELIVERY SYSTEM AORTIC TRANSCATHETER HEART VALVE BIO-PROSTHETIC, SCENT-LIKE FRAMEWORK in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2021-00323 and manufactured by Boston Scientific Corporation - MA, USA mfd. By: Symetis SA - Ecublens, Switzerland in Switzerland. The device was registered on December 07, 2021.

This page provides complete registration details including manufacturer information, importer/distributor details (Boston Scientific Philippines Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free DatabasePowered by Pure Global AIFDA Official DataSwitzerland